14-3-3ζ Cooperates with ErbB2 to Promote Ductal Carcinoma In Situ Progression to Invasive Breast Cancer by Inducing Epithelial-Mesenchymal Transition
Open Access
- 8 September 2009
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 16 (3), 195-207
- https://doi.org/10.1016/j.ccr.2009.08.010
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Regulation of In Situ to Invasive Breast Carcinoma TransitionCancer Cell, 2008
- LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasisMolecular Cancer Therapeutics, 2008
- Development of TGF-β signalling inhibitors for cancer therapyNature Reviews Drug Discovery, 2004
- Homeostasis in the breast: It takes a villageCancer Cell, 2004
- Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breastEuropean Journal of Cancer, 2003
- Conserved role for 14‐3‐3ϵ downstream of type I TGFβ receptorsFEBS Letters, 2001
- The E-cadherin–catenin complex in tumour metastasis: structure, function and regulationEuropean Journal of Cancer, 2000
- The Hallmarks of CancerCell, 2000
- Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breastEuropean Journal of Cancer, 1996